217 related articles for article (PubMed ID: 21354598)
41. The method of bladder cuff excision during laparoscopic radical nephroureterectomy does not affect oncologic outcomes in upper tract urothelial carcinoma.
Allard CB; Alamri A; Dason S; Farrokhyar F; Matsumoto ED; Kapoor A
World J Urol; 2013 Feb; 31(1):175-81. PubMed ID: 22843075
[TBL] [Abstract][Full Text] [Related]
42. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
43. The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract.
Miyake H; Hara I; Gohji K; Arakawa S; Kamidono S
Br J Urol; 1998 Oct; 82(4):494-8. PubMed ID: 9806176
[TBL] [Abstract][Full Text] [Related]
44. Perioperative outcomes of robot-assisted nephroureterectomy for upper urinary tract urothelial carcinoma: a multi-institutional series.
Pugh J; Parekattil S; Willis D; Stifelman M; Hemal A; Su LM
BJU Int; 2013 Aug; 112(4):E295-300. PubMed ID: 23879914
[TBL] [Abstract][Full Text] [Related]
45. Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience.
Shirotake S; Kikuchi E; Tanaka N; Matsumoto K; Miyazaki Y; Kobayashi H; Ide H; Obata J; Hoshino K; Kaneko G; Hagiwara M; Kosaka T; Kanao K; Kodaira K; Hara S; Oyama M; Momma T; Miyajima A; Nakagawa K; Hasegawa S; Nakajima Y; Oya M
J Urol; 2015 Apr; 193(4):1122-8. PubMed ID: 25444957
[TBL] [Abstract][Full Text] [Related]
46. Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and Health Care Costs.
Del Giudice F; van Uem S; Li S; Vilson FL; Sciarra A; Salciccia S; Busetto GM; Maggi M; Tiberia L; Viscuso P; Canale V; Panebianco V; Pecoraro M; Ferro M; Moschini M; Krajewski W; D'Andrea D; Cacciamani GE; Mari A; Soria F; Porpiglia F; Fiori C; Amparore D; Checcucci E; Autorino R; De Berardinis E; Chung BI
Clin Genitourin Cancer; 2022 Apr; 20(2):198.e1-198.e9. PubMed ID: 35031226
[TBL] [Abstract][Full Text] [Related]
47. Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes.
Kobayashi K; Saito T; Kitamura Y; Bilim V; Toba T; Kawasaki T; Hara N; Tanikawa T; Tomita Y
Int J Urol; 2016 Feb; 23(2):153-8. PubMed ID: 26607995
[TBL] [Abstract][Full Text] [Related]
48. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery?
Rassweiler JJ; Schulze M; Marrero R; Frede T; Palou Redorta J; Bassi P
Eur Urol; 2004 Dec; 46(6):690-7. PubMed ID: 15548434
[TBL] [Abstract][Full Text] [Related]
49. Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.
Lee KS; Kim KH; Yoon YE; Choi KH; Yang SC; Han WK
Korean J Urol; 2015 Jan; 56(1):41-7. PubMed ID: 25598935
[TBL] [Abstract][Full Text] [Related]
50. Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control.
Matin SF; Gill IS
J Urol; 2005 Feb; 173(2):395-400. PubMed ID: 15643179
[TBL] [Abstract][Full Text] [Related]
51. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
[TBL] [Abstract][Full Text] [Related]
52. Perioperative chemotherapy for upper tract urothelial cancer.
Alva AS; Matin SF; Lerner SP; Siefker-Radtke AO
Nat Rev Urol; 2012 Apr; 9(5):266-73. PubMed ID: 22487872
[TBL] [Abstract][Full Text] [Related]
53. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer.
Song W; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
Urol Oncol; 2017 Mar; 35(3):114.e1-114.e7. PubMed ID: 27908680
[TBL] [Abstract][Full Text] [Related]
54. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
[TBL] [Abstract][Full Text] [Related]
55. A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02.
Necchi A; Martini A; Raggi D; Cucchiara V; Colecchia M; Lucianò R; Villa L; Mazzone E; Basile G; Scuderi S; Pederzoli F; Bandini M; Barletta F; Larcher A; Capitanio U; Salonia A; Briganti A; Ross JS; Messina A; Montorsi F
Urol Oncol; 2022 Jan; 40(1):10.e1-10.e6. PubMed ID: 34147313
[TBL] [Abstract][Full Text] [Related]
56. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the Cleveland Clinic experience.
Gill IS; Sung GT; Hobart MG; Savage SJ; Meraney AM; Schweizer DK; Klein EA; Novick AC
J Urol; 2000 Nov; 164(5):1513-22. PubMed ID: 11025694
[TBL] [Abstract][Full Text] [Related]
57. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
[TBL] [Abstract][Full Text] [Related]
58. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
[TBL] [Abstract][Full Text] [Related]
59. Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.
Adibi M; McCormick B; Economides MP; Petros F; Xiao L; Guo C; Shah A; Kamat AM; Dinney C; Navai N; Gao J; Siefker-Radtke A; Matin SF; Campbell MT
Clin Genitourin Cancer; 2022 Apr; 20(2):176-182. PubMed ID: 35039231
[TBL] [Abstract][Full Text] [Related]
60. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
